Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic

The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially rebounding in many sectors since July. We expect this trend and activity to continue at least through year-end.

This guidebook is intended to provide a deeper dive into COVID-19-related transactional matters for private equity buyers or platforms to consider, including in connection with the evaluation of a target’s receipt of stimulus funds under the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) and the negotiation of key deal terms in the acquisition agreement. You can consult any of the authors listed in the guidebook for more information, as well as your regular Bass, Berry & Sims contacts.

Please see full Publication below for more infomation.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bass, Berry & Sims PLC | Attorney Advertising

Written by:

Bass, Berry & Sims PLC
Contact
more
less

Bass, Berry & Sims PLC on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.